Zhang H - Search Results

1

Reply to Kesici et al. and Zeng et al.: Blocking the virus and reducing the inflammatory damage in COVID-19.

Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, Zhou M, Chen L, Chen Z, Zhang X, Yang X. Duan K, et al. Among authors: zhang h, zhang x. Proc Natl Acad Sci U S A. 2020 Jun 9;117(23):12529-12530. doi: 10.1073/pnas.2007408117. Epub 2020 May 12. Proc Natl Acad Sci U S A. 2020. PMID: 32398377 Free PMC article. No abstract available.

2

Effectiveness of convalescent plasma therapy in severe COVID-19 patients.

Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, Zhou M, Chen L, Meng S, Hu Y, Peng C, Yuan M, Huang J, Wang Z, Yu J, Gao X, Wang D, Yu X, Li L, Zhang J, Wu X, Li B, Xu Y, Chen W, Peng Y, Hu Y, Lin L, Liu X, Huang S, Zhou Z, Zhang L, Wang Y, Zhang Z, Deng K, Xia Z, Gong Q, Zhang W, Zheng X, Liu Y, Yang H, Zhou D, Yu D, Hou J, Shi Z, Chen S, Chen Z, Zhang X, Yang X. Duan K, et al. Among authors: zhang l, zhang w, zhang j, zhang z, zhang h, zhang x. Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496. doi: 10.1073/pnas.2004168117. Epub 2020 Apr 6. Proc Natl Acad Sci U S A. 2020. PMID: 32253318 Free PMC article.

3

Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.

Xia S, Duan K, Zhang Y, Zhao D, Zhang H, Xie Z, Li X, Peng C, Zhang Y, Zhang W, Yang Y, Chen W, Gao X, You W, Wang X, Wang Z, Shi Z, Wang Y, Yang X, Zhang L, Huang L, Wang Q, Lu J, Yang Y, Guo J, Zhou W, Wan X, Wu C, Wang W, Huang S, Du J, Meng Z, Pan A, Yuan Z, Shen S, Guo W, Yang X. Xia S, et al. Among authors: zhang l, zhang w, zhang h, zhang y. JAMA. 2020 Sep 8;324(10):951-960. doi: 10.1001/jama.2020.15543. JAMA. 2020. PMID: 32789505 Free PMC article. Clinical Trial.

4

Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal models.

Wang ZJ, Zhang HJ, Lu J, Xu KW, Peng C, Guo J, Gao XX, Wan X, Wang WH, Shan C, Zhang SC, Wu J, Yang AN, Zhu Y, Xiao A, Zhang L, Fu L, Si HR, Cai Q, Yang XL, You L, Zhou YP, Liu J, Pang DQ, Jin WP, Zhang XY, Meng SL, Sun YX, Desselberger U, Wang JZ, Li XG, Duan K, Li CG, Xu M, Shi ZL, Yuan ZM, Yang XM, Shen S. Wang ZJ, et al. Emerg Microbes Infect. 2020 Dec;9(1):2606-2618. doi: 10.1080/22221751.2020.1852059. Emerg Microbes Infect. 2020. PMID: 33241728 Free PMC article.

5

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.

Guo W, Duan K, Zhang Y, Yuan Z, Zhang YB, Wang Z, Zhao D, Zhang H, Xie Z, Li X, Peng C, Zhang W, Yang Y, Chen W, Gao X, You W, Wang XW, Shi Z, Wang Y, Yang XQ, Zhang L, Huang L, Wang Q, Lu J, Yang YL, Guo J, Zhou W, Wan X, Wu C, Wang W, Du J, Nian X, Li XH, Huang S, Shen S, Xia S, Pan A, Yang X. Guo W, et al. Among authors: zhang l, zhang yb, zhang w, zhang h, zhang y. EClinicalMedicine. 2021 Aug;38:101010. doi: 10.1016/j.eclinm.2021.101010. Epub 2021 Jul 7. EClinicalMedicine. 2021. PMID: 34250456 Free PMC article.

6

Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylactics.

Zhao S, Zhang H, Yang X, Zhang H, Chen Y, Zhan Y, Zhang X, Jiang R, Liu M, Liu L, Chen L, Tang W, Peng C, Gao X, Zhang Z, Shi Z, Gong R. Zhao S, et al. Among authors: zhang z, zhang h, zhang x. Nat Commun. 2021 Aug 9;12(1):4887. doi: 10.1038/s41467-021-25153-x. Nat Commun. 2021. PMID: 34373446 Free PMC article.

7

Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 Trial.

Xia S, Duan K, Zhang Y, Zeng X, Zhao D, Zhang H, Xie Z, Li X, Peng C, Zhang W, Yang Y, Chen W, Gao X, You W, Wang X, Wang Z, Shi Z, Wang Y, Yang X, Li Q, Huang L, Wang Q, Lu J, Yang Y, Guo J, Zhou W, Wan X, Wu C, Wang W, Huang S, Du J, Nian X, Deng T, Yuan Z, Shen S, Guo W, Liu J, Yang X. Xia S, et al. Among authors: zhang w, zhang h, zhang y. Front Immunol. 2022 Jun 24;13:898151. doi: 10.3389/fimmu.2022.898151. eCollection 2022. Front Immunol. 2022. PMID: 35812412 Free PMC article. Clinical Trial.

8

Potent human neutralizing antibodies against Nipah virus derived from two ancestral antibody heavy chains.

Chen L, Sun M, Zhang H, Zhang X, Yao Y, Li M, Li K, Fan P, Zhang H, Qin Y, Zhang Z, Li E, Chen Z, Guan W, Li S, Yu C, Zhang K, Gong R, Chiu S. Chen L, et al. Among authors: zhang z, zhang k, zhang h, zhang x. Nat Commun. 2024 Apr 6;15(1):2987. doi: 10.1038/s41467-024-47213-8. Nat Commun. 2024. PMID: 38582870 Free PMC article.

9

Ferritin nanoparticle-based Nipah virus glycoprotein vaccines elicit potent protective immune responses in mice and hamsters.

Chen S, Zhang X, Yao Y, Wang S, Li K, Zhang B, Ye T, Chen L, Wu Y, Li E, Xu B, Zhang P, Chuai X, Ran Y, Gong R, Zhang H, Chiu S. Chen S, et al. Among authors: zhang b, zhang p, zhang x, zhang h. Virol Sin. 2024 Dec;39(6):909-916. doi: 10.1016/j.virs.2024.09.005. Epub 2024 Sep 16. Virol Sin. 2024. PMID: 39293542 Free PMC article.

10

Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2.

Jiang RD, Liu MQ, Chen Y, Shan C, Zhou YW, Shen XR, Li Q, Zhang L, Zhu Y, Si HR, Wang Q, Min J, Wang X, Zhang W, Li B, Zhang HJ, Baric RS, Zhou P, Yang XL, Shi ZL. Jiang RD, et al. Cell. 2020 Jul 9;182(1):50-58.e8. doi: 10.1016/j.cell.2020.05.027. Epub 2020 May 21. Cell. 2020. PMID: 32516571 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130,575 results

Search Page

Filters